DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Kruse-Jarres R, Callaghan MU, Croteau SE. , et al.
Surgical experience in two multicenter, open-label phase 3 studies of emicizumab in persons with hemophilia A with inhibitors (HAVEN 1 and HAVEN 2).
Blood 2017;
130 (Suppl. 01) 89
We do not assume any responsibility for the contents of the web pages of other providers.